Clinical Trials Directory

Trials / Completed

CompletedNCT05348330

Mid-point to Pleura Transverse Process Block Versus Thoracic Intervertebral Foramen Block

Mid-point to Pleura Transverse Process Continuous Block Versus Thoracic Intervertebral Foramen Continuous Block, for Analgesia in Polytraumatic Patients with Multiple Rib Fractures

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
100 (actual)
Sponsor
San Salvatore Hospital of L'Aquila · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The analgesic effect of continuous mid-point to pleura transverse process block compared to the analgesic effect of continuous thoracic intervertebral foramen block, in patients with multiple rib fractures.

Detailed description

The analgesic effect of continuous mid-point to pleura transverse process block will be compared to the analgesic effect of continuous thoracic intervertebral foramen block, in patients with multiple rib fractures, by using the numeric rating scale (NRS) for pain.

Conditions

Interventions

TypeNameDescription
PROCEDUREThoracic intervertebral foramen blockUnder ultrasound guidance the continuous thoracic intervertebral foramen block, will be provided to achieve analgesia in polytraumatic patients with rib fractures. A set for continuous peripheral nerve block will be used. The infusion rate of analgesic solution (levobupivacaine 0.25% combined with dexamethasone 16 mg) will be titrated to patient perceived pain. The block will be performed close, by considering the level of rib fractures.
PROCEDUREMid-point to pleura transverse process blockUnder ultrasound guidance the continuous mid-point to pleura transverse process block, will be provided to achieve analgesia in polytraumatic patients with rib fractures. A set for continuous peripheral nerve block will be used. The infusion rate of analgesic solution (levobupivacaine 0.25% combined with dexamethasone 16 mg) will be titrated to patient perceived pain. The block will be performed close, by considering the level of rib fractures.

Timeline

Start date
2022-12-04
Primary completion
2024-10-31
Completion
2024-11-28
First posted
2022-04-27
Last updated
2024-12-03

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT05348330. Inclusion in this directory is not an endorsement.